Neuralink didn’t say much else about the trial, including the country in which the study will take place. However, the company says patients who’ve already been accepted into

Neuralink has announced its entering the next phase of development of a brain-computer interface that involves the use of robotic arm.

Neuralink, Elon Musk’s brain-tech company, is starting a new trial to see if its brain chip can control robotic arms. The study, called “CONVOY,” will use the company’s N1 implant to help people with severe paralysis perform physical tasks independently.